Trademark Overview
On Friday, December 19, 2025, a trademark application was filed for CLEAR CROSSING with the United States Patent and Trademark Office. The USPTO has given the CLEAR CROSSING trademark a serial number of 99557550. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, April 22, 2026. This trademark is owned by Endorel Biosciences LLC. The CLEAR CROSSING trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
pharmaceutical research and development; biochemical research and development; research and development in the field of drug delivery and drug delivery systems; chemical analysis of biological and chemical compounds; chemical analysis services; scientific and technological services, namely, peptide synthesis for biological and medical research; scientific and technological services, namely, peptide synthesis for manufacturers of biological and medical research products
drug delivery agents consisting of compounds that facilitate delivery of wide range of pharmaceuticals; drug delivery agents in the form of powders and liquids that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that improve the efficacy of other drug delivery agents, all to facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations for intracellular delivery of drugs or therapeutic substances; preparations for intracellular delivery of biological or chemical compounds for biological research
